IOS Press

Alzheimer's disease & dementia

New diagnostic biomarkers offer ray of hope for Alzheimer's disease

Alzheimer's disease (AD) is one of the most common brain disorders, with an estimated 35 million people affected worldwide. In the last decade, research has advanced our understanding of how AD affects the brain. However, ...

Parkinson's & Movement disorders

19th century therapy for Parkinson's disease may help patients today

In the 19th century, the celebrated neurologist, Jean-Martin Charcot, developed a "vibration chair" to relieve symptoms of Parkinson's disease. He reported improvements in his patients, but he died shortly thereafter and ...

Alzheimer's disease & dementia

Moral emotions, a diagnotic tool for frontotemporal dementia?

A study conducted by Marc Teichmann and Carole Azuar at the Brain and Spine Institute in Paris (France) and at the Pitié-Salpêtrière Hospital shows a particularly marked impairment of moral emotions in patients with frontotemporal ...

Alzheimer's disease & dementia

Second Phase 3 study results for LMTX published

TauRx Therapeutics Ltd today reported the full results from its second Phase 3 clinical study of LMTX, the first tau aggregation inhibitor in Alzheimer's disease, published online in the Journal of Alzheimer's Disease.

page 12 from 40